Title of article :
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Author/Authors :
Eric V. Dang، نويسنده , , Joseph Barbi، نويسنده , , Huang-Yu Yang، نويسنده , , Dilini Jinasena، نويسنده , , Hong Yu، نويسنده , , Ying Zheng، نويسنده , , Zachary Bordman، نويسنده , , Juan Fu، نويسنده , , Young Kim، نويسنده , , Hung-Rong Yen، نويسنده , , Weibo Luo، نويسنده , , Karen Zeller، نويسنده , , Larissa Shimoda، نويسنده , , Suzanne L. Topalian، نويسنده , , Gregg L. Semenza، نويسنده , , Chi V. Dang، نويسنده , , Drew M. Pardoll، نويسنده , , Fan Pan، نويسنده ,
Issue Information :
هفته نامه با شماره پیاپی سال 2011
Pages :
13
From page :
772
To page :
784
Abstract :
T cell differentiation into distinct functional effector and inhibitory subsets is regulated, in part, by the cytokine environment present at the time of antigen recognition. Here, we show that hypoxia-inducible factor 1 (HIF-1), a key metabolic sensor, regulates the balance between regulatory T cell (Treg) and TH17 differentiation. HIF-1 enhances TH17 development through direct transcriptional activation of RORγt and via tertiary complex formation with RORγt and p300 recruitment to the IL-17 promoter, thereby regulating TH17 signature genes. Concurrently, HIF-1 attenuates Treg development by binding Foxp3 and targeting it for proteasomal degradation. Importantly, this regulation occurs under both normoxic and hypoxic conditions. Mice with HIF-1α-deficient T cells are resistant to induction of TH17-dependent experimental autoimmune encephalitis associated with diminished TH17 and increased Treg cells. These findings highlight the importance of metabolic cues in T cell fate determination and suggest that metabolic modulation could ameliorate certain T cell-based immune pathologies.
Journal title :
CELL
Serial Year :
2011
Journal title :
CELL
Record number :
1020816
Link To Document :
بازگشت